Guerbet (XPAR:GBT) Short Interest


XPAR:GBT Guerbet SA XPAR:GBT
68 GF Score
Price €9.18
GF Value €19.65
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Guerbet Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XPAR:GBT vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, Guerbet's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guerbet Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Guerbet's Short Interest distribution charts can be found below:

* The bar in red indicates where Guerbet's Short Interest falls into.


XPAR:GBT
68GF Score
Guerbet SA XPAR:GBT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guerbet (XPAR:GBT) Overvalued in 2026?

Based on GuruFocus' analysis, Guerbet stock appears to be undervalued. The current stock price of €9.18 is trading 53.3% below its estimated GF Value™ of €19.65. GuruFocus considers Guerbet to be Possible Value Trap.

Key valuation signals for XPAR:GBT:

  • Short Interest:
  • GF Value™: €19.65 vs. price of €9.18 (53.3% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the XPAR:GBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guerbet Business Description

Other Exchanges 0ELV:UK4G8:Germany
Address 15 rue des Vanesses, Zone Paris Nord II, Villepinte, FRA, 93420
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.
68GF Score

Get the complete analysis for XPAR:GBT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.18
Price
€19.65
GF Value